Patents Assigned to Stemirna Therapeutics Co., Ltd.
  • Methods of using microRNA-199A
    Patent number: 10577608
    Abstract: Provided herein are methods of treating a cancer in an individual. A microRNA-199a oligonucleotide or mimic that increases the expression of microRNA-199a in the cancer cell is administered to the individual. Also provided is a method of inhibiting proliferation of a cancer cell and treating a cell associated with a cancer. The cell is contacted with the microRNA-199a oligonucleotide or mimic.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: March 3, 2020
    Assignee: Stemirna Therapeutics Co., Ltd.
    Inventors: Dean Tang, Ruifang Liu
  • Methods of using microRNA-141
    Patent number: 10202604
    Abstract: Provided herein are methods of treating a cancer in an individual. A microRNA-141 oligonucleotide or mimic that increases the expression of microRNA-141 in the cancer cell is administered to the individual. Also provided is a method of inhibiting proliferation of a cancer cell and treating a cell associated with a cancer. The cell is contacted with the microRNA-141 oligonucleotide or mimic.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: February 12, 2019
    Assignee: Stemirna Therapeutics Co., Ltd.
    Inventors: Dean Tang, Can Liu
  • Methods of Using MicroRNA-141
    Publication number: 20170342417
    Abstract: Provided herein are methods of treating a cancer in an individual. A microRNA-141 oligonucleotide or mimic that increases the expression of microRNA-141 in the cancer cell is administered to the individual. Also provided is a method of inhibiting proliferation of a cancer cell and treating a cell associated with a cancer. The cell is contacted with the microRNA-141 oligonucleotide or mimic.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Applicant: Stemirna Therapeutics Co., Ltd.
    Inventors: Dean Tang, Can Liu
  • Methods of Using MicroRNA-199A
    Publication number: 20170342421
    Abstract: Provided herein are methods of treating a cancer in an individual. A microRNA-199a oligonucleotide or mimic that increases the expression of microRNA-199a in the cancer cell is administered to the individual. Also provided is a method of inhibiting proliferation of a cancer cell and treating a cell associated with a cancer. The cell is contacted with the microRNA-199a oligonucleotide or mimic.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Applicant: Stemirna Therapeutics Co., Ltd.
    Inventors: Dean Tang, Ruifang Liu